NCT05746533 An Evaluation of Hip Preservation Outcomes
| NCT ID | NCT05746533 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Yale University |
| Condition | Hip Arthroscopy |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2023-06-02 |
| Primary Completion | 2053-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2023-06-02 with a primary completion date of 2053-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to assess outcomes of hip preservation surgeries including open and arthroscopic treatment of femoroacetabular impingement (FAI).
Eligibility Criteria
Inclusion Criteria: * Candidates for surgical intervention of the hip * Participant and/or guardian has given informed consent and assent as applicable. Exclusion Criteria: * Documented history of pre-existing hip conditions (SCFE, LCPD, acetabular fractures) * Has language or cognitive barriers preventing understanding of study and consent and assent documents * Prior revision surgeries * Patients from the trauma/emergency department * Individuals with Unusable x-rays
Contact & Investigator
Andrew Jimenez, MD
PRINCIPAL INVESTIGATOR
Yale University
Frequently Asked Questions
Who can join the NCT05746533 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, studying Hip Arthroscopy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05746533 currently recruiting?
Yes, NCT05746533 is actively recruiting participants. Contact the research team at andrew.jimenez@yale.edu for enrollment information.
Where is the NCT05746533 trial being conducted?
This trial is being conducted at New Haven, United States.
Who is sponsoring the NCT05746533 clinical trial?
NCT05746533 is sponsored by Yale University. The principal investigator is Andrew Jimenez, MD at Yale University. The trial plans to enroll 10,000 participants.